123 related articles for article (PubMed ID: 22790822)
1. A concise synthesis of a very late antigen-4 antagonist trans-4-[1-[[2,5-dichloro-4-(1-methyl-3-indolylcarboxyamide)phenyl]acetyl]-(4S)-methoxy-(2S)-pyrrolidinylmethoxy]cyclohexanecarboxylic acid via reductive etherification.
Chiba J; Muro F; Setoguchi M; Machinaga N
Chem Pharm Bull (Tokyo); 2012; 60(7):882-6. PubMed ID: 22790822
[TBL] [Abstract][Full Text] [Related]
2. A novel synthetic approach to very late antigen-4 antagonist trans-4-[1-[[2,5-dichloro-4-(1-methyl-3-indolylcarboxyamide)phenyl]acetyl]-(4S)-methoxy-(2S)-pyrrolidinylmethoxy]cyclohexanecarboxylic acid via tert-butyl trans-[(4S)-Methoxy-(2S)-pyrrolidinylmethoxy]cyclohexanecarboxylate as a key intermediate.
Chiba J; Machinaga N
Chem Pharm Bull (Tokyo); 2011; 59(5):574-8. PubMed ID: 21532195
[TBL] [Abstract][Full Text] [Related]
3. Discovery of trans-4-[1-[[2,5-Dichloro-4-(1-methyl-3-indolylcarboxamido)phenyl]acetyl]-(4S)-methoxy-(2S)-pyrrolidinylmethoxy]cyclohexanecarboxylic acid: an orally active, selective very late antigen-4 antagonist.
Muro F; Iimura S; Sugimoto Y; Yoneda Y; Chiba J; Watanabe T; Setoguchi M; Iigou Y; Matsumoto K; Satoh A; Takayama G; Taira T; Yokoyama M; Takashi T; Nakayama A; Machinaga N
J Med Chem; 2009 Dec; 52(24):7974-92. PubMed ID: 19891440
[TBL] [Abstract][Full Text] [Related]
4. Identification of trans-4-[1-[[7-fluoro-2-(1-methyl-3-indolyl)-6-benzoxazolyl]acetyl]-(4S)-fluoro-(2S)-pyrrolidinylmethoxy]cyclohexanecarboxylic acid as a potent, orally active VLA-4 antagonist.
Setoguchi M; Iimura S; Sugimoto Y; Yoneda Y; Chiba J; Watanabe T; Muro F; Iigo Y; Takayama G; Yokoyama M; Taira T; Aonuma M; Takashi T; Nakayama A; Machinaga N
Bioorg Med Chem; 2012 Feb; 20(3):1201-12. PubMed ID: 22261021
[TBL] [Abstract][Full Text] [Related]
5. A novel, potent, and orally active VLA-4 antagonist with good aqueous solubility: trans-4-[1-[[2-(5-Fluoro-2-methylphenylamino)-7-fluoro-6-benzoxazolyl]acetyl]-(5S)-[methoxy(methyl)amino]methyl-(2S)-pyrrolidinylmethoxy]cyclohexanecarboxylic acid.
Setoguchi M; Iimura S; Sugimoto Y; Yoneda Y; Chiba J; Watanabe T; Muro F; Iigo Y; Takayama G; Yokoyama M; Taira T; Aonuma M; Takashi T; Nakayama A; Machinaga N
Bioorg Med Chem; 2013 Jan; 21(1):42-61. PubMed ID: 23218775
[TBL] [Abstract][Full Text] [Related]
6. Improvement of pulmonary function by oral treatment with a VLA-4 antagonist in a mouse asthmatic model.
Takayama G; Matsumoto K; Taira T; Aonuma M; Yokoyama M; Iigo Y; Takashi T
J Pharmacol Sci; 2013; 121(2):172-5. PubMed ID: 23419271
[TBL] [Abstract][Full Text] [Related]
7. A novel and potent VLA-4 antagonist based on trans-4-substituted cyclohexanecarboxylic acid.
Muro F; Iimura S; Yoneda Y; Chiba J; Watanabe T; Setoguchi M; Takayama G; Yokoyama M; Takashi T; Nakayama A; Machinaga N
Bioorg Med Chem; 2009 Feb; 17(3):1232-43. PubMed ID: 19124247
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and pharmacological activity of 4-amino-5-chloro-2-methoxy-N-[(2S,4S)-1-ethyl-2-hydroxymethyl-4- pyrrolidinyl]benzamide (TKS159) and its optical isomers.
Yanagi T; Kitajima A; Anzai K; Kodama K; Mizoguchi J; Fujiwara H; Sakiyama H; Kamoda O; Kamei C
Chem Pharm Bull (Tokyo); 1999 Nov; 47(11):1650-4. PubMed ID: 10605060
[TBL] [Abstract][Full Text] [Related]
9. Stereoselective synthesis of iso-dolaproine via dynamic kinetic resolution.
Lavergne D; Mordant C; Ratovelomanana-Vidal V; Genet JP
Org Lett; 2001 Jun; 3(12):1909-12. PubMed ID: 11405742
[TBL] [Abstract][Full Text] [Related]
10. Identification of 4-[1-[3-chloro-4-[N'-(5-fluoro-2-methylphenyl)ureido]phenylacetyl]-(4S)-fluoro-(2S)-pyrrolidinylmethoxy]benzoic acid as a potent, orally active VLA-4 antagonist.
Muro F; Iimura S; Yoneda Y; Chiba J; Watanabe T; Setoguchi M; Iigou Y; Takayama G; Yokoyama M; Takashi T; Nakayama A; Machinaga N
Bioorg Med Chem; 2008 Dec; 16(23):9991-10000. PubMed ID: 18952443
[TBL] [Abstract][Full Text] [Related]
11. A new approach to 3-hydroxyprolinol derivatives by samarium diiodide-mediated reductive coupling of chiral nitrone with carbonyl compounds.
Wu SF; Zheng X; Ruan YP; Huang PQ
Org Biomol Chem; 2009 Jul; 7(14):2967-75. PubMed ID: 19582307
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of 2,3-disubstituted pyrrolidines and piperidines via one-pot oxidative decarboxylation-beta-iodination of amino acids.
Boto A; Hernández R; de León Y; Suárez E
J Org Chem; 2001 Nov; 66(23):7796-803. PubMed ID: 11701038
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of enantiopure trans-2,5-disubstituted trifluoromethylpyrrolidines and (2S,5R)-5-trifluoromethylproline.
Lubin H; Pytkowicz J; Chaume G; Sizun-Thomé G; Brigaud T
J Org Chem; 2015 Mar; 80(5):2700-8. PubMed ID: 25643061
[TBL] [Abstract][Full Text] [Related]
14. Asymmetric synthesis of the cis- and trans-stereoisomers of 4-aminopyrrolidine-3-carboxylic acid and 4-aminotetrahydrofuran-3-carboxylic acid.
Bunnage ME; Davies SG; Roberts PM; Smith AD; Withey JM
Org Biomol Chem; 2004 Oct; 2(19):2763-76. PubMed ID: 15455148
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and glycosidase inhibition evaluation of (3S,4S)-3-((R)-1,2-dihydroxyethyl)pyrrolidine-3,4-diol.
Zhang E; Bai PY; Sun W; Wang S; Wang MM; Xu SM; Liu HM
Carbohydr Res; 2016 Nov; 434():33-36. PubMed ID: 27563841
[TBL] [Abstract][Full Text] [Related]
16. Versatile one-pot reductive alkylation of lactams/amides via amide activation: application to the concise syntheses of bioactive alkaloids (±)-bgugaine, (±)-coniine, (+)-preussin, and (-)-cassine.
Xiao KJ; Wang Y; Ye KY; Huang PQ
Chemistry; 2010 Nov; 16(43):12792-6. PubMed ID: 20938943
[No Abstract] [Full Text] [Related]
17. A fast, efficient and stereoselective synthesis of hydroxy-pyrrolidines.
Dangerfield EM; Gulab SA; Plunkett CH; Timmer MS; Stocker BL
Carbohydr Res; 2010 Jul; 345(10):1360-5. PubMed ID: 20363468
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and determination of absolute configuration of a non-peptidic αvβ6 integrin antagonist for the treatment of idiopathic pulmonary fibrosis.
Anderson NA; Campbell IB; Fallon BJ; Lynn SM; Macdonald SJ; Pritchard JM; Procopiou PA; Sollis SL; Thorp LR
Org Biomol Chem; 2016 Jul; 14(25):5992-6009. PubMed ID: 27226381
[TBL] [Abstract][Full Text] [Related]
19. Stereoselective synthesis of a MCHr1 antagonist.
Andersen D; Storz T; Liu P; Wang X; Li L; Fan P; Chen X; Allgeier A; Burgos A; Tedrow J; Baum J; Chen Y; Crockett R; Huang L; Syed R; Larsen RD; Martinelli M
J Org Chem; 2007 Dec; 72(25):9648-55. PubMed ID: 17997573
[TBL] [Abstract][Full Text] [Related]
20. First chemoenzymatic synthesis of (+)-2-carboxypyrrolidine-3-acetic acid, the nucleus of kainoid amino acids.
Felluga F; Forzato C; Nitti P; Pitacco G; Ghelfi F; Valentin E
Chirality; 2012 Feb; 24(2):112-8. PubMed ID: 22180179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
